MEDINCELL

MedinCell is a technology-based pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas, combining its proprietary technology with active substances already known and marketed. Its treatments provide the patient better tolerance and a single injection that avoids repeated and potentially forgotten doses.

• 6 M€ turnover
• 110 employees
• Pipeline of 10 programs